Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
45
# OF OVERLAPPING
HOLDINGS
WDNA
90
HOLDINGS
54%
ALSO IN IBB
IBB
251
HOLDINGS
21%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 3.0% | 6.2% | 3.0% |
|
NATERA INC | 4.4% | 2.3% | 2.3% |
|
UNITED THERAPEUTICS CORP | 2.2% | 1.9% | 1.9% |
|
GILEAD SCIENCES INC | 1.9% | 7.3% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.5% | 6.2% | 1.5% |
WDNA Overweight Relative to IBB
|
BLUEPRINT MEDICINES CORP. | 3.8% |
 |
NOVOZYMES A/S-B SHARES | 3.2% |
|
BRIDGEBIO PHARMA, INC. | 3.1% |
|
ELI LILLY & CO | 2.3% |
|
STOKE THERAPEUTICS, INC. | 2.2% |
|
NATERA INC | 2.1% |
|
TWIST BIOSCIENCE CORP. | 2.0% |
|
AGIOS PHARMACEUTICALS INC | 1.9% |
 |
NOVARTIS AG | 1.9% |
|
VERACYTE INC | 1.8% |
WDNA Underweight Relative to IBB
|
GILEAD SCIENCES INC | -5.4% |
|
REGENERON PHARMACEUTICALS | -5.3% |
|
AMGEN INC | -5.2% |
|
VERTEX PHARMACEUTICALS INC | -4.7% |
|
IQVIA HOLDINGS INC | -3.4% |
|
INSMED INC | -3.2% |
|
ALNYLAM PHARMACEUTICALS INC | -3.2% |
|
METTLER-TOLEDO INTERNATIONAL | -2.8% |
 |
ARGENX SE ADR | -1.9% |
|
BEIGENE LTD. SPONSORED ADR | -1.9% |